Hong Kong Economic and Trade Office, San Francisco
Hong Kong
Hong Kong a medical research hub – international collaboration on establishing The Center for Neurodegenerative Diseases

Chief Executive Carrie Lam
This milestone occasion brings together four of the world’s leading universities - and from three continents - for pioneering medical research here in Hong Kong. It is indeed the fourth occasion of an MoU signing ceremony for such collaborative research that I had witnessed in the past seven months. The other three MoU signing occasions involved equally distinguished and renowned institutions from France, Germany and the United States. One could not help thinking that this is clear and compelling testimony of Hong Kong’s singular ability to create connections, to help people, businesses and institutions excel, whatever they’re pursuing, whatever their vision. That said, I must thank those overseas renowned universities and research institutions for placing their trust in us, and our local Consulates for helping us to connect. The presence today of the United Kingdom Consul General and the Acting Consul General of the United States is much appreciated.

The Chief Executive, Mrs Carrie Lam, speaks at the signing ceremony of the Memorandum of Understanding for Establishing The Center for Neurodegenerative Diseases on January 16. The centre is to be established by the Hong Kong University of Science and Technology (HKUST), Harvard Medical School, Stanford University School of Medicine and University College London.
The Chief Executive, Mrs Carrie Lam, speaks at the signing ceremony of the Memorandum of Understanding for Establishing The Center for Neurodegenerative Diseases on January 16. The centre is to be established by the Hong Kong University of Science and Technology (HKUST), Harvard Medical School, Stanford University School of Medicine and University College London.

Developing Hong Kong into an innovation and technology (I&T) hub is central to my Government’s economic policy. In my maiden Policy Address delivered in October 2017, which is just three months after I have assumed the office of the Chief Executive, I set out eight major areas for our innovation and technology progress, including expanding our infrastructure, pooling technology talent and boosting research and development (R&D) funding. Since then, my Government has allocated about US$10 billion for I&T initiatives, including significant resources for R&D activities. Among other things, we are bolstering R&D in our universities and public research institutes. We have also instituted a super tax deduction of up to 300% to private enterprises for their R&D expenditure.

No less important, we have set aside US$1.3 billion to establish two research clusters - one for healthcare, the other for artificial intelligence and robotics. The good news is the newly created partnership we are witnessing today will apply for participation in the healthcare research cluster - known as health@InnoHK. Specifically, the Hong Kong University of Science & Technology, Boston Children’s Hospital, a Harvard Medical School Teaching Hospital, Stanford University School of Medicine and University College London will conduct research on neurodegenerative diseases, working out of Hong Kong Science Park.

As we all know, neurodegenerative diseases, particularly Alzheimer’s, are becoming more prevalent in ageing populations. And while understanding of neurodegenerative diseases continues to advance, there are few effective treatments available, either to delay the onset or to affect the course of Alzheimer’s and other daunting neurodegenerative diseases.

I am, however, hopeful that the combined excellence and collective commitment and expertise of four of the world’s leading institutions, and their scientists and researchers, can lead to significant advances in the diagnosis and treatment of neurodegenerative diseases. I am also confident that this research consortium will create wide-ranging, world-class opportunities for the next generation of Hong Kong scientists and researchers, and in doing so, establish Hong Kong as an international centre for research in neurodegenerative diseases.

Chief Executive Carrie Lam gave these remarks at the Memorandum of Understanding for Establishing The Center for Neurodegenerative Diseases signing ceremony on January 16.

The Chief Executive, Mrs Carrie Lam, attended the signing ceremony of the Memorandum of Understanding for Establishing The Center for Neurodegenerative Diseases on January 16. The centre is to be established by the Hong Kong University of Science and Technology (HKUST), Harvard Medical School, Stanford University School of Medicine and University College London. Photo shows Mrs Lam (back row, third left); the Secretary for Innovation and Technology, Mr Nicholas W Yang (back row, second right); the Chairman of the Council of HKUST, Mr Andrew Liao (back row, third right); the President of HKUST, Professor Shyy Wei (back row, second left); the British Consul General to Hong Kong and Macao, Mr Andrew Heyn (back row, first left); and the Acting Consul General of the United States to Hong Kong and Macau, Mr Thomas Hodges (back row, first right), witnessing representatives signing the Memorandum of Understanding.
The Chief Executive, Mrs Carrie Lam, attended the signing ceremony of the Memorandum of Understanding for Establishing The Center for Neurodegenerative Diseases on January 16. The centre is to be established by the Hong Kong University of Science and Technology (HKUST), Harvard Medical School, Stanford University School of Medicine and University College London. Photo shows Mrs Lam (back row, third left); the Secretary for Innovation and Technology, Mr Nicholas W Yang (back row, second right); the Chairman of the Council of HKUST, Mr Andrew Liao (back row, third right); the President of HKUST, Professor Shyy Wei (back row, second left); the British Consul General to Hong Kong and Macao, Mr Andrew Heyn (back row, first left); and the Acting Consul General of the United States to Hong Kong and Macau, Mr Thomas Hodges (back row, first right), witnessing representatives signing the Memorandum of Understanding.
  The Chief Executive, Mrs Carrie Lam, attended the signing ceremony of the Memorandum of Understanding for Establishing The Center for Neurodegenerative Diseases on January 16. The centre is to be established by the Hong Kong University of Science and Technology (HKUST), Harvard Medical School, Stanford University School of Medicine and University College London. Photo shows Mrs Lam (front row, fourth left); the Secretary for Innovation and Technology, Mr Nicholas W Yang (front row, first right); the Chairman of the Council of HKUST, Mr Andrew Liao (front row, fifth left); the President of HKUST, Professor Shyy Wei (front row, second right); the British Consul General to Hong Kong and Macao, Mr Andrew Heyn (front row, first left); and other guests at the ceremony.
The Chief Executive, Mrs Carrie Lam, attended the signing ceremony of the Memorandum of Understanding for Establishing The Center for Neurodegenerative Diseases on January 16. The centre is to be established by the Hong Kong University of Science and Technology (HKUST), Harvard Medical School, Stanford University School of Medicine and University College London. Photo shows Mrs Lam (front row, fourth left); the Secretary for Innovation and Technology, Mr Nicholas W Yang (front row, first right); the Chairman of the Council of HKUST, Mr Andrew Liao (front row, fifth left); the President of HKUST, Professor Shyy Wei (front row, second right); the British Consul General to Hong Kong and Macao, Mr Andrew Heyn (front row, first left); and other guests at the ceremony.


       2019 © | Important notices     Privacy policy      Accessibility                                                                                                                                               Last Revision Date: February 4, 2019

 

Web For All W3C Web Accessibility initiative    
This website adopts web accessibility design and conforms to the World Wide Web Consortium (W3C) Web Content Accessibility Guidelines (WCAG) 2.0 Level AA standard. Should you have any enquiries or comments on its accessibility, please contact us by phone or email.